Scinovex
article Open AccessTop 1% cited

Pharmacokinetics and Pharmacodynamics of a Sustained-Release Dexamethasone Intravitreal Implant

Investigative Ophthalmology & Visual Science · 2010 · Vol. 52(1) · pp. 80–80
Joan-En Chang-LinMayssa AttarAndrew AcheampongMichael R. RobinsonScott M. WhitcupBaruch D. KuppermannDevin Welty

Abstract

The in vivo release profile of the DEX implant in an animal eye was similar to the pharmacokinetics achieved with pulse administration of corticosteroids (high initial drug concentration, followed by a prolonged period of low concentration). These results are consistent with those in clinical studies supporting the use of the DEX implant for the extended management of posterior segment diseases.

Retinal Diseases and TreatmentsGlaucoma and retinal disordersIntraocular Surgery and LensesPharmacokineticsDexamethasoneImplantPharmacodynamicsMedicineIn vivoRetinaChemistryPharmacologyEndocrinology

MeSH terms

AnimalsBiological AvailabilityChromatography, High Pressure LiquidDelayed-Action PreparationsDexamethasoneDrug ImplantsGlucocorticoidsHalf-LifeMacaca fascicularisMaleRetinaTissue DistributionVitreous BodyGene Expression Regulation, EnzymologicArea Under Curve
Citations
583
FWCI
19.40
field-weighted impact
References
48
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.